We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MLSR:TASEMelisron Limited Analysis

Data as of 2026-05-28 - not real-time

€19.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just below its short‑term moving averages, with the short‑term average edging lower than the medium‑term line, indicating a weakening price trend. The MACD histogram sits in negative territory and the signal line is bearish, reinforcing the downward momentum. RSI is positioned in the lower half of its scale, suggesting limited buying pressure. Volume has been shrinking, and the price is hovering near a key support zone while facing a nearby resistance barrier. Volatility over the past month is markedly elevated, and the beta figure points to modest correlation with the broader market. Valuation multiples such as the price‑to‑earnings and price‑to‑book are substantially above typical levels for the consumer defensive sector.
Fundamentally, the company shows strong profit margins but zero revenue growth and no cash generation, raising concerns about sustainability. The absence of dividend payments eliminates income‑focused appeal. Combined with thin trading activity, the liquidity profile is weak, making large positions difficult to unwind. Given these dynamics, the outlook leans toward caution across horizons. Investors should weigh the overvalued pricing against the modest growth prospects and high volatility before deciding.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish technical indicators
  • price near support with limited upside
  • poor liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • overvalued multiples
  • stable profit margins
  • stagnant revenue growth

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • high valuation without growth
  • absence of dividend
  • elevated volatility

Key Metrics & Analysis

Financial Health

Profit Margin61.05%
P/E Ratio53.5
ROE5.90%
ROA0.51%
P/B Ratio4.2

Technical Analysis

TrendBearish
RSI38.7
Support€18.60
Resistance€20.60
MA 20€20.36
MA 50€20.62
MA 200€29.69
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.29
Volatility66.66%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.